Does Qsymia make you dizzy?

Yes, and it is on the label rather than only in reports: dizziness appears among the common adverse reactions in Qsymia's FDA prescribing information, published 2026-04-24. Listed means it was seen often enough in the trials to be printed, not that it happens to everyone. On this site dizziness is listed by two different kinds of drug and it does not mean the same thing on each. On the GLP-1 medicines it usually follows the fluid and salt lost with a much smaller intake, and it shows up as the room swimming on standing up. On the stimulant-based tablets it more often comes with the rise in heart rate and blood pressure the label describes. Either way it is worth measuring rather than guessing, because the two point in opposite directions. It clusters in the days after each dose increase. Qsymia steps up on a published schedule that reaches the maintenance dose at week 3. Most people see a few rough days after each step and a settling in between, not one long stretch. Once you are at 7.5 mg / 46 mg daily and no longer stepping up, the trigger stops recurring. What helps first: standing up slowly, and noticing whether it happens specifically on standing — that pattern is dehydration until proven otherwise. It stops being ordinary at a specific line: fainting, dizziness with chest pain or palpitations, or a spinning sensation that does not settle when you sit. Also anything that arrives with sweating and confusion, which on a drug taken alongside insulin or a sulfonylurea is low blood sugar rather than dizziness.